Elevance Health, Inc.

NYSE:ELV Voorraadrapport

Marktkapitalisatie: US$98.0b

Elevance Health Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Elevance Health is de winst gegroeid met een gemiddeld jaarlijks percentage van 7.1%, terwijl de Healthcare industrie de winst jaarlijks groeide met 5.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 11.2% per jaar. Het rendement op eigen vermogen van Elevance Health is 14.6%, en het heeft een nettomarge van 3.7%.

Belangrijke informatie

7.1%

Groei van de winst

9.1%

Groei van de winst per aandeel

Healthcare Groei van de industrie8.5%
Inkomstengroei11.2%
Rendement op eigen vermogen14.6%
Nettomarge3.7%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Oct 29
We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Recent updates

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Oct 29
We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds

Oct 17

Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%

Oct 10

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Oct 08
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Sep 11
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth

Sep 06

There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Aug 29
There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Aug 02
Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Elevance Health: Healthcare Services Segment Is Gaining Traction

Jul 31

Elevance Health: Buy A Dividend Growth Machine

Jul 18

Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)

Jun 28

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Jun 11
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

May 27
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

May 09
We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Apr 25
Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

Apr 23

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Apr 16
Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Apr 11

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Apr 01
Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Mar 21

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Mar 07

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Jan 19
Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Is Elevance Health (NYSE:ELV) A Risky Investment?

Jan 02
Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Dec 18
Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

A Look At Elevance's Margin Dynamics

Nov 23

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Nov 16
Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Elevance Health: A High Conviction Defensive Blue Chip Buy

Oct 19

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Oct 04
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Sep 21

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Sep 18
Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Sep 13

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Aug 18
If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Aug 04
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Jul 24

Elevance Health: Beaten Down Share Price Offers Solid Potential

Jul 10

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Jul 05
Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health: A Critical Update (Rating Downgrade)

Jun 05

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Jun 04
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

May 05
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Apr 04
We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Opbrengsten en kosten

Hoe Elevance Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NYSE:ELV Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 24174,0156,41837,3830
30 Jun 24171,7196,69137,4070
31 Mar 24171,7456,24436,6660
31 Dec 23171,3405,98736,2360
30 Sep 23168,6265,99635,7180
30 Jun 23165,7166,31033,5530
31 Mar 23160,6766,09431,7490
31 Dec 22156,5995,89430,6960
30 Sep 22153,2516,16629,6050
30 Jun 22149,1346,07228,4960
31 Mar 22144,3536,22827,5900
31 Dec 21138,6436,15826,6040
30 Sep 21133,8835,51826,3570
30 Jun 21129,2194,23125,8390
31 Mar 21124,6324,71425,6750
31 Dec 20121,8684,57225,2020
30 Sep 20117,4494,95523,0130
30 Jun 20112,9655,91620,8500
31 Mar 20109,1674,77917,9550
31 Dec 19104,2124,80715,3560
30 Sep 19100,1654,29814,3230
30 Jun 1996,7424,07413,7060
31 Mar 1994,2203,98913,7580
31 Dec 1892,0913,75014,0200
30 Sep 1891,4094,55613,6810
30 Jun 1890,5844,34413,1460
31 Mar 1890,0614,14512,7720
31 Dec 1790,0493,84312,6500
30 Sep 1789,0552,98012,5200
30 Jun 1788,0382,85112,6340
31 Mar 1787,0832,77712,5490
31 Dec 1684,8622,47012,5590
30 Sep 1683,3642,28212,5620
30 Jun 1681,8662,31912,5180
31 Mar 1680,4122,39812,5900
31 Dec 1579,1582,56012,5350
30 Sep 1577,9592,88612,2990
30 Jun 1576,6052,86212,1870
31 Mar 1575,0662,73412,0320
31 Dec 1473,8862,56011,7480
30 Sep 1472,7922,36211,3610
30 Jun 1472,0902,38510,9360
31 Mar 1471,3072,45310,4850
31 Dec 1371,0242,6349,9530

Kwaliteitswinsten: ELV heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (3.7%) ELV } zijn hoger dan vorig jaar (3.6%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van ELV is de afgelopen 5 jaar met 7.1% per jaar gegroeid.

Versnelling van de groei: De winstgroei van ELV over het afgelopen jaar ( 7% ) ligt onder het 5-jarig gemiddelde ( 7.1% per jaar).

Winst versus industrie: De winstgroei ELV over het afgelopen jaar ( 7% ) overtrof de Healthcare -sector 10.4%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 14.6% ) van ELV wordt als laag beschouwd.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y